Palantir Stock Plunged First: Is the Bottom in 2026?
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
Explore the unique financial literacy challenges women face and how to overcome them. Empower your financial journey with vital insights.
28,655 articlesPalantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
President Trump nominates Cameron Hamilton to run FEMA, marking a surprising return to a central agency as disaster r...
A prominent fund dumped its monday.com stake in a move that coincided with a steep stock decline. This article breaks...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
A sharp job split shows healthcare added about 900,000 positions while other sectors shed jobs. Investors are reasses...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...
With rates steady and mobility rising, financial advisors contend that the decision to rent or buy depends on your li...
A governance gap in autonomous AI agents threatens personal finances as firms rush AI adoption. Experts warn that unc...